Plain-English translation of NCT06625060 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can help prevent migraines in adults. The treatment is given as injections into muscles in the head, face, and neck. Researchers want to find the best dose and confirm it works safely for people who experience migraines regularly.
Many people with migraines don't have enough options to prevent their headaches, or existing treatments don't work well enough for them. This study is exploring whether this new treatment could offer another way to reduce how often migraines occur.
You likely qualify if…
You likely don't qualify if…
The study has two main steps. In Step 1, a smaller group of participants will receive either the medication or a placebo injection to test whether it is safe at two different doses. In Step 2, a larger group of participants will be randomly assigned to receive one of two doses of the medication or a placebo injection, depending on whether they have episodic or chronic migraines. All participants will receive injections into muscles of the head, face, and neck, and will be monitored for safety and effectiveness over 36 weeks.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States